FDA Declines to Approve MDMA Therapy, and Seeks Further Studynews2024-08-10T11:56:53+00:00August 10th, 2024|The New York Times|
Veterans and Lawmakers Lobby for Approval of MDMA Therapynews2024-08-08T22:01:37+00:00August 8th, 2024|The New York Times|
FDA Panel Rejects Use of MDMA for Treatment of PTSDnews2024-06-04T23:06:17+00:00June 4th, 2024|The New York Times|
What Are the MDMA Risks of Therapy for PTSD?news2024-06-04T22:12:47+00:00June 4th, 2024|The New York Times|
Why PTSD Is So Hard to Diagnose and Treatnews2024-06-04T22:00:17+00:00June 4th, 2024|The New York Times|
FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flawsnews2024-05-31T19:08:30+00:00May 31st, 2024|The New York Times|
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapynews2024-03-05T18:32:51+00:00March 5th, 2024|The New York Times|
FDA Issues Warning Over Misuse of Ketamine Therapynews2023-10-11T20:50:31+00:00October 11th, 2023|The New York Times|
Psilocybin Helps Alleviate Depression Symptoms, Small Study Saysnews2022-04-11T19:54:55+00:00April 11th, 2022|The New York Times|
